[KSoLA 1] | Apr. 15 (Fri.) 16:45-17:30 Rm.203 | |
---|---|---|
Debate: Are Big-data Studies Over-rated? | ||
Chairperson(s) | 김명아, 이상학 | |
Panel | 김규리, 진흥용 | |
16:45-17:00 | No, It has Big Advantages & Can Almost Replace RCTs | 김경민 / 연세의대 |
17:00-17:15 | Yes, Drawbaks are Clear & It Cannot Replace RCTs | 원호연 / 중앙의대 |
17:15-17:30 | Discussion |
[KSoLA 2] | Apr. 16 (Sat.) 08:00-09:40 Rm.203 | |
---|---|---|
Current Concepts in Pathophysiology of Atherosclerosis | ||
Chairperson(s) | 박경수, 최동훈 | |
Panel | 박성하, 황지원 | |
08:00-08:15 | Role of Adipose Tissue in Atherosclerosis | 최성희 / 서울의대 |
08:15-08:30 | Clonality and Plasticity of Vascular Smooth Muscle Cells | 허경선 / 충남대 |
08:30-08:45 | Understanding Results of Single Cell Sequencing | 김용숙 / 전남의대 |
08:45-09:00 | New Paradigm for Atherosclerosis; Brain Neurobiology is Linked with Plaque Inflammation | 김진원 / 고려의대 |
09:00-09:30 | Discussion |
[KSoLA 3] | Apr. 16 (Sat.) 09:50-11:30 Rm.203 | |
---|---|---|
Secret of Development of New Drugs in Atherosclerosis | ||
Chairperson(s) | 장학철, 김재범 | |
Panel | 강현재, 박영미, 이승준 | |
09:50-10:10 | Know-how of Target Discovery (with Innovative Target Discovery Platform for Metabolic Diseases, iClue-TDMD) | 최철수 / 가천의대 |
10:10-10:30 | Comparing Platforms: siRNA, ASO, Ab, and Compound for the Treatment of Dyslipidemia | 박정숙 / 충남대 |
10:30-10:50 | Which Target would Survive? Metabolism, Inflammation, or Aging? | 조경아 / 전남의대 |
10:50-11:20 | Discussion |
[KSoLA 4] | Apr. 16 (Sat.) 15:00-16:30 Rm.203 | |
---|---|---|
Lifestyle Factors in COVID-19 Pandemic | ||
Chairperson(s) | 박중열, 한성림 | |
Panel | 김대중, 임정현, 전성완 | |
15:00-15:20 | COVID-19 & Changes in Korean Consumers' Dietary Attitude and Behavior | 윤지현 / 서울대 |
15:20-15:40 | Obesity as a Risk Factor for COVID-19: Is Physical Exercise the Answer? | 곽이섭 / 동아대 |
15:40-16:00 | Updated Dietary Guidelines to Promote Cardiovascular Health | 송수진 / 한남대 |
16:00-16:30 | Discussion |
[KSoLA 5] | Apr. 16 (Sat.) 16:40-18:10 Rm.203 | |
---|---|---|
New Korean Lipid Guidelines Now | ||
Chairperson(s) | 김치정, 김재택 | |
Panel | 김철식, 최성훈 | |
16:40-17:00 | How Can We Assess CV Risk for Korean People for Differential Tx? | 이찬주 / 연세의대 |
17:00-17:20 | Which Target LDL-C for Very High/High Risk Groups? | 김상현 / 서울의대 |
17:20-17:40 | What Risk Grading is Best for DM Patients for Differential Lipid Lowering Therapy? | 김경수 / 차의대 |
17:40-18:10 | Discussion |